Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: A cross-sectional study

BMC Cancer

Volumn 9, Issue , 2009, Pages 275-

  Moodley, Jennifer R ^a   Constant, Deborah ^a   Hoffman, Margaret ^a   Salimo, Anna ^a   Allan, Bruce ^a   Rybicki, Ed ^a   Hitzeroth, Inga ^a   Williamson, Anna Lise ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SOUTH AFRICA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVIX UTERI; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 70349849367     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-275     Document Type: Article

References (39)

1. Mqoqi N, Kellet P, Madhoo J, Sitas F. Cancer in South Africa, 1996-1997. National Cancer Registry of South Africa 2003, National Health Laboratory Service, Johannesburg.
2. Department of Health of South Africa The national HIV and syphilis prevalence survey South Africa, 2007. Annual report National Department of Health, Pretoria 2008,
3. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283:1031-1037. 10.1001/jama.283.8.1031, 10697063.
4. Wright TC, Ellerbrock TV, Chiasson MA, Sun XW, Van Devanter N, . the New York Cervical Disease Study Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and the validity of Papaniculou smears. Obst Gynecol 1994, 84:591-597.
5. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV) positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236. 10.1093/jnci/91.3.226, 10037100.
6. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in women infected with human immunodeficiency virus. N Engl J Med 1997, 337:1343-1349. 10.1067/mob.2002.123607, 9358128.
7. Tate DR, Anderson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case control analysis. Am J Obstet Gynecol 2002, 186:880-882. 10.1097/01.lgt.0000245038.06977.a7, 12015501.
8. Massad LS, Fazzari MJ, Anastos K, Klein RS, Minkoff H, Jamieson DJ, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts DH, Levine AM, Schuman P, Harris TG, Strickler HD. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis 2007, 1(2):90-97.
9. Hawes SE, Critchlow CW, Niang MAF, Diouf MB, Diop A, Toure P, Kasse AA, Dembele B, Sow PS, Coll-Seck AM, Kuypers JM, Kiviat NB. Increased Risk of High-Grade Cervical Squamous Intraepithelial Lesions and Invasive Cervical Cancer among African Women with Immunodeficiency Virus Type 1 and 2 Infections. JID 2003, 188:555-563. 10.1086/376996, 12898443.
10. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, Anderson J, Shah KV, . for the Epidemiology Research Study (HERS) Group Longitudinal Study of Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus (HIV)-Seropositive and At-Risk HIV-Seronegative Women. JID 2003, 188:128-136. 10.1086/520883, 12825181.
11. Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 2007, 196(6):887-94. 17703420, 10.1086/520883.
12. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, Denny LE, Shapiro S, Williamson AL. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer 2006, 6:135. 10.1186/1471-2407-6-135, 1481580, 16719902.
13. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: a prospective cohort study. Swiss HIV Cohort Study. BMJ 1999, 319:23-24. 28149, 10390454.
14. Jacobsen LP. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-infected individuals. J Acquir Immune Defic Syndr 1999, 21:S34-S41.
15. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Current opinion in Oncology 2003, 15:382-388. 10.1097/00001622-200309000-00007, 12960521.
16. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004, 9(1):13-22.
17. Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 2008, 111(6):1380-1387. 18515522.
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N, . Forum Group Members; Bethesda 2001 Workshop The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287(16):2114-2119. 10.1001/jama.287.16.2114, 11966386.
19. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999, 21(1):33-41. 10.1097/00002030-200008180-00013, 10235512.
20. Delmas MC, Larsen C, Van Benthem B, Hamers FF, Bergeron C, Poveda JD, Anzen B, Hoek A, Meier F, Pena JM, Savonius H, Sperandeo D, Suligoi B, Vernazza P, Brunet JB, De Vincenzi I, . for the European Study Group on Natural History of HIV Infection in Women Cervical squamous intraepithelial lesions in HIV infected women: prevalence, incidence and regression. AIDS 2000, 14:1775-1784. 10985315, 10.1097/00002030-200008180-00013.
21. Ahdieh L, Muñoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000, 151(12):1148-1157. 10.1016/j.ygyno.2006.06.015, 10905527.
22. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006, 103(3):1017-1022. 10.1016/j.ygyno.2006.06.015, 16875716.
23. Anorlu RI, Igwilo CI, Akanmu AS, Banjo AA, Odunukwe NN, Okany CC, Abudu OO, Dim ST. Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria. West Afr J Med 2007, 26(2):143-147. 17939318.
24. Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P, Cu-Uvin S, Shah K, . HIV Epidemiology Research Study (HERS) Group Characterization of genital human papillomavirus infection in women. Am J Obstet Gynecol 2002, 186(1):21-27. 10.1067/mob.2002.119776, 11810079.
25. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Viro 2006, 35(3):264-269.
26. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001, 83:95-99. 10.1006/gyno.2001.6336, 11585419.
27. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Onco 2004, 92(1):225-231.
28. Pretet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J Clin Virol 2004, 31:140-147. 10.1016/j.jcv.2004.02.008, 15364271.
29. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. A Comparison between Real-Time Polymerase Chain Reaction and Hybrid Capture 2 for Human Papillomavirus DNA Quantitation. Cancer Epidemiol Biomark Prev 2003, 12:477-484.
30. Clifford GM, Gonçalves MA, Franceschi S, . HPV and HIV Study Group Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20(18):2337-2344. 17117020, 10.1097/01.aids.0000253361.63578.14.
31. Ho GY, Burk RD, Klein S, Kadish AS, Chan CJ, Palan P, Basu J, Farthing A, Masterson P, Mason WP, Vousden KH. Persistent genital human papillomavirusinfection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995, 87:1365-1371. 10.1093/jnci/91.11.954, 7658497.
32. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, Burk RD, Kurman RJ, Wacholder S, Rush BB, Cadell DM, Lawler P, Tabor D, Schiffman M. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999, 91:954-960. 10359548, 10.1093/jnci/91.11.954.
33. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro ME, Sherman S, Wacholder S, Chen A, Rodriguez C, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1796-1807. 15871111, 10.1086/428850.
34. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, . IARC HPV Prevalence Surveys Study Group Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998. 10.1086/505876, 16168781.
35. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, Reichman RC. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Di 2006, 194(4):428-434.
36. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 2007, 96(9):1480-1483.
37. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S. Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the Women's Interagency HIV Study. J Acquir Immun Defic Syndr 2001, 27:432-442.
38. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995, 141(7):680-689.
39. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000, 132(10):810-819.